With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...

Researchers from two universities will use a £300,000 grant from Ochre to study OSCC, a subtype of oesophageal cancer.

The research team at UQ has secured a grant of $344,000 from the National Foundation for Medical Research and Innovation.

A MAN has warned other ‘stubborn’ blokes not to ignore symptoms – after an ‘ingrown hair’ he tried to cover with his beard ...

Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but ...

Researchers from the University of Dundee and Queen’s University Belfast have been awarded £300,000 funding to investigate ...

At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in ...